Bifonazole/Crotamiton/Lidocaine/Glycyrrhetinic Acid/Levomenthol

联苯苄唑/克罗米通/利多卡因/甘草次酸/左旋薄荷醇

Report date: 2026/02/13 10:40:18

Base Information

Drug NameBifonazole/Crotamiton/Lidocaine/Glycyrrhetinic Acid/Levomenthol

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionLanosterol 14α-demethylase inhibitorsSodium channel alpha subunit modulatorsCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors +[6]

TargetsLanosterol 14α-demethylaseSodium channel alpha subunitCorticosteroid 11-beta-dehydrogenase isozyme 1 +[6]

Therapy Area/IndicationsTinea PedisTinea

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsYes Bifonazole Crotamiton Lidocaine

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsTinea PedisTinea

Inactive IndicationsN/A

Other Information

ATC CodeN/A